Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1730 of 6351
-
New combo therapy aims to shrink deadly esophageal tumors
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and efficacy of a new treatment approach for T4-stage esophageal cancer, which involves chemoradiotherapy after induction chemotherapy. The main questions it aims to answer are: * Does the new induction chemotherapy fo…
Phase 1/2 • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could immune cells in fat hold the key to Obesity-Related diseases?
Knowledge-focused Recruiting nowThe goal of this study is to evaluate the role of transcription factor EB (TFEB) in adipose (fat) tissue macrophages (ATM) in regulating adipose tissue and systemic metabolic function in obesity. The investigators will assess the differences in ATM lipid metabolism in people with…
Sponsor: Bettina Mittendorfer • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers in first human test
Disease control OngoingThis is a first-in-human, Phase 1, non-randomized, multicenter, open-label clinical study designed to investigate the safety, tolerability, dosimetry, biodistribution, and pharmacokinetics (PK) of \[225Ac\]-FPI-2068, \[111In\]-FPI-2107, and FPI-2053 in metastatic and/or recurrent…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug could help liver disease patients avoid bleeding during surgery
Disease control CompletedThis study includes Part A and Part B. Part A is a dose-finding study for subjects with chronic liver disease-related thrombocytopenia scheduled for elective surgery. Part B is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study designed to evalua…
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
French study tracks Ivosidenib's Real-World impact on Hard-to-Treat leukemia
Disease control Recruiting nowMutations in IDH genes are found in numerous cancers and more specifically in acute myeloid leukemia (AML). These mutations target specific amino acids, at positions 140 or 172 of IDH2, and 132 of IDH1. Mutant IDH proteins acquire an abnormal enzymatic activity allowing them to c…
Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can melatonin or special lights fix long COVID sleep issues?
Symptom relief CompletedThe platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure that can be shared by multiple interventions and allows comparative analysis across…
Phase 2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New stroke drug BB-031 enters human testing
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of stroke onset. Participants will be randomized to receive one dose of either the …
Phase 2 • Sponsor: Basking Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Probiotics may shield cancer patients from Immunotherapy's gut woes
Prevention PausedThe clinical trial tests the use of over-the-counter probiotics VSL#3® 450B in patients receiving immunotherapy. Immunotherapy with monoclonal antibodies, helps the body's immune system attack tumor cells, and interferes with the ability of tumor cells to grow and spread. Immunot…
Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
New pill targets Hard-to-Treat cancers with hippo pathway mutations
Disease control Recruiting nowThis is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed…
Phase 1 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Water pill could boost kidney Drug's power and cut side effects
Disease control Recruiting nowAutosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive formation of renal cysts which ultimately lead to a loss of renal function. Tolvaptan (a V2R antagonist) is currently the only effective treatment for preserving renal function in ADPKD. However…
Phase 3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Period blood may hold key to endometriosis diagnosis
Diagnosis Recruiting nowThe goal of this observational study is to identify diagnostic and prognostic biomarkers for endometriosis using menstrual blood, an easily accessible yet overlooked biological fluid in women of reproductive age, affected or not by endometriosis The main questions it aims to ans…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
New device could spare colon cancer patients from temporary stoma
Disease control CompletedA feasibility study to assess the early safety and effectiveness of the Colovac 2 device in providing temporary protection of the anastomosis in patients undergoing low anterior resection for colon cancer.
Sponsor: SafeHeal Inc • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Virtual coach aims to ease chronic pain in veterans
Symptom relief Recruiting nowPain has been identified as among the most frequent presenting medical complaints, in particular within primary care for Veterans. There are few areas of daily living and functioning that pain intensity does not impact, with reported pain intensity related to difficulties in soci…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Triple therapy shrinks head and neck tumors before surgery in early trial
Disease control CompletedThe purpose of this study was to evaluate the safety and tolerability of low-dose radiotherapy plus tislelizumab in combination with afatinib neoadjuvant therapy for patients with surgically resectable squamous carcinoma of the head and neck.
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Real-world MS drug study tracks relapse reduction in italian patients
Disease control OngoingStudy to evaluate the effectiveness of ofatumumab in Italian RRMS patients in the real-life setting.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a $4 pill slash stroke risk after brain surgery? new trial aims to find out.
Disease control Recruiting nowAPICES trial is an investigator-initiated, multicenter, multicenter, randomized, double-blind, placebo-controlled clinical trial that plans to enroll 396 patients with a 1-year follow-up, including a neurovascular imaging examination \[digital subtraction angiography (DSA), CT an…
Phase 4 • Sponsor: Duan Chuanzhi • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New kidney drug B007 takes on cyclosporine in major trial
Disease control Recruiting nowTo evaluate the efficacy and safety of B007 in the Treatment of Primary Membranous Nephropathy
Phase 2/3 • Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a malaria drug help sarcoidosis patients ditch steroids?
Disease control Recruiting nowSarcoidosis is a systemic granulomatous disease of unknown aetiology, mainly affecting the lungs and lymphatics. It affects people worldwide (incidence, 4.7-64/100000; prevalence, 1-36/100000/year). Although it is most often a benign acute or subacute condition, sarcoidosis may p…
Phase 4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 17:09 UTC
-
New lupus drug tested for Long-Term safety in 680 patients
Disease control By invitation onlyThe goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients with moderate to severe symptoms of systemic lupus erythematosus. The main questions it aims to answer are: * Whether cenerimod causes any adverse effects ('si…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Light therapy shows promise for Hard-to-Heal diabetic foot sores
Disease control CompletedDiabetic foot ulcer affects 10.5% of the Brazilian/world population, compromising the quality of life of these patients and burdening the public health system. Studies show that antimicrobial photodynamic therapy (aPDT) accelerates its repair, however, there is not enough evidenc…
Sponsor: University of Nove de Julho • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC